- Home
- LH vs BNTX Comparison
LH vs BNTX Comparison
Compare LH & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LH | BNTX |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | LH | BNTX |
|---|---|---|
| Price | $251.92 | $99.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $301.33 | $137.40 |
| AVG Volume (30 Days) | 592.3K | ★ 1.1M |
| Earning Date | 02-05-2026 | 11-03-2025 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 98.36 | N/A |
| EPS | ★ 10.19 | N/A |
| Revenue | ★ $13,765,300,000.00 | $3,698,814,972.00 |
| Revenue This Year | $10.80 | $2.03 |
| Revenue Next Year | $4.43 | N/A |
| P/E Ratio | $25.00 | ★ N/A |
| Revenue Growth | ★ 8.28 | 3.70 |
| 52 Week Low | $209.38 | $81.20 |
| 52 Week High | $293.72 | $126.77 |
Technical Indicators
Market Signals| Indicator | LH | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 60.82 |
| Support Level | $251.17 | $95.85 |
| Resistance Level | $261.73 | $101.48 |
| Average True Range (ATR) | 4.55 | 1.87 |
| MACD | 0.35 | 0.94 |
| Stochastic Oscillator | 45.28 | 84.15 |
Price Performance
Historical ComparisonAbout LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.